Public Hearing on Genetic Diagnostic Testing Patents

The PTO has posted the initial schedule for the first public hearing on genetic diagnostic testing patents.  Note that there is time allotted for those who did not pre-schedule their testimony, in case you missed the deadline.

Public Hearing on Genetic Diagnostic Testing

United States Patent and Trademark Office (USPTO)

600 Dulany Street, Alexandria VA

Madison Auditorium

 

 

Thursday, February 16, 2012

9:00 a.m. – 4:00 p.m.

Agenda

WebEx Information

Event number: 992 693 923 Event password: 123456 Event address for attendees: https://uspto-events.webex.com/uspto-events/onstage/g.php?d=992693923&t=a

Teleconference information

Call-in toll number (US/Canada): +1(408) 600 – 3600 Access code: 992 693 923

United States Patent and Trademark Office Panel

Teresa Stanek Rea, Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office

Dana Robert Colarulli, Director, Office of Governmental Affairs

Janet Gongola, Patent Reform Coordinator

Stuart Graham, Chief Economist

George Elliott, Technology Center Director (Biotechnology)

9:00 AM: Welcoming Remarks

Teresa Stanek Rea, Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office

9:10 AM: Opening Commentary (Video)

Congresswoman Debbie Wasserman Schultz, U.S. House of Representatives

9:20 AM: General Commentary for Congressionally-Mandated Studies Under the AIA

Janet Gongola, Patent Reform Coordinator

9:25 AM: Overview of Genetic Diagnostic Testing Study

Stuart Graham, Chief Economist

9:35 AM: Scheduled Testimony

9:35 – 10:05 AM

Thomas Kowalski, Shareholder, Vedder Price, P.C.

10:05 – 10:20 AM

Mercedes Meyer, Member, Board of Directors, American Intellectual Property Law Association

10:20 – 10:35 AM

Break

10:35 – 10:45 AM

Mary Williams, Executive Director, Association for Molecular Pathology

10:45 – 11:00 AM

Lori Pressman, Independent Consultant on Technology Transfer

11:00 – 11:15 AM

Hans Sauer, Associate General Counsel for Intellectual Property, Biotechnology Industry Organization

11:15 – 11:25 AM

Ellen Jorgensen, President, Genspace

11:25 – 11:35 AM

Lawrence Horn, CEO, MPEG LA, LLC Kristin Neuman, Executive Director, Librassay™, MPEG LA, LLC

11:35 – 11:45 AM

Lisa Schlager, Vice President, Community Affairs & Public Policy, FORCE

11:45 – 12:05 AM

Kevin Noonan, Partner, McDonnell Boehnen Hulbert & Berghoff LLP

 

12:05 PM: Break for Lunch

1:30 PM: Open Floor for Unscheduled Testimony

Closing Remarks      Janet Gongola, Patent Reform Coordinator

Comments are closed.